Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology

2004 ◽  
Vol 1022 (1-2) ◽  
pp. 164-172 ◽  
Author(s):  
Kelly J. Conn ◽  
Wenwu Gao ◽  
Ann McKee ◽  
Michael S. Lan ◽  
M. David Ullman ◽  
...  
2018 ◽  
Vol 293 (48) ◽  
pp. 18421-18433 ◽  
Author(s):  
Takushi Fujimoto ◽  
Orie Nakamura ◽  
Michiko Saito ◽  
Akio Tsuru ◽  
Masaki Matsumoto ◽  
...  

2006 ◽  
Vol 281 (44) ◽  
pp. 33727-33738 ◽  
Author(s):  
Heli I. Alanen ◽  
Richard A. Williamson ◽  
Mark J. Howard ◽  
Feras S. Hatahet ◽  
Kirsi E. H. Salo ◽  
...  

2007 ◽  
Vol 282 (46) ◽  
pp. 33859-33867 ◽  
Author(s):  
Johannes Haugstetter ◽  
Michael Andreas Maurer ◽  
Thomas Blicher ◽  
Martin Pagac ◽  
Gerhard Wider ◽  
...  

Disulfide bond formation in the endoplasmic reticulum is catalyzed by enzymes of the protein disulfide-isomerase family that harbor one or more thioredoxin-like domains. We recently discovered the transmembrane protein TMX3, a thiol-disulfide oxidoreductase of the protein disulfide-isomerase family. Here, we show that the endoplasmic reticulum-luminal region of TMX3 contains three thioredoxin-like domains, an N-terminal redox-active domain (named a) followed by two enzymatically inactive domains (b and b′). Using the recombinantly expressed TMX3 domain constructs a, ab, and abb′, we compared structural stability and enzymatic properties. By structural and biophysical methods, we demonstrate that the reduced a domain has features typical of a globular folded domain that is, however, greatly destabilized upon oxidization. Importantly, interdomain stabilization by the b domain renders the a domain more resistant toward chemical denaturation and proteolysis in both the oxidized and reduced form. In combination with molecular modeling studies of TMX3 abb′, the experimental results provide a new understanding of the relationship between the multidomain structure of TMX3 and its function as a redox enzyme. Overall, the data indicate that in addition to their role as substrate and co-factor binding domains, redox-inactive thioredoxin-like domains also function in stabilizing neighboring redox-active domains.


Leukemia ◽  
2018 ◽  
Vol 33 (4) ◽  
pp. 1011-1022 ◽  
Author(s):  
Reeder M. Robinson ◽  
Leticia Reyes ◽  
Ravyn M. Duncan ◽  
Haiyan Bian ◽  
Allen B. Reitz ◽  
...  

Author(s):  
Zhao-Feng Li ◽  
Lei Cui ◽  
Mi-Mi Jin ◽  
Dong-Yan Hu ◽  
Xiao-Gang Hou ◽  
...  

Parkinson's disease (PD) is featured with α-synuclein-based Lewy body pathology, which however was difficult to observe in conventional two-dimensional (2D) cell culture and even in animal models. We herein aimed to develop a three-dimensional (3D) cellular model of PD to recapitulate the α-synuclein pathologies. All-trans-retinoic acid-differentiated human SH-SY5Y cells and Matrigel were optimized for 3D construction. The 3D cultured cells displayed higher tyrosine hydroxylase expression and improved dopaminergic-like phenotypes than 2D cells as suggested by RNA-sequencing analyses. Multiple forms of α-synuclein, including monomer, low and high molecular weight oligomers, were differentially present in the 2D and 3D cells, but mostly remained unchanged upon the MPP+ or rotenone treatment. Phosphorylated α-synuclein was accumulated and detergent-insoluble α-synuclein fraction was observed in the neurotoxin-treated 3D cells. Importantly, Lewy body-like inclusions were captured in the 3D system, including proteinase K-resistant α-synuclein aggregates, ubiquitin aggregation, β-amyloid and β-sheet protein deposition. The study provides a unique and convenient 3D model of PD which recapitulates critical α-synuclein pathologies and should be useful in multiple PD-associated applications.


Sign in / Sign up

Export Citation Format

Share Document